Company intelligence / Profile preview

VaxTrials

Panama City, Panama Province, Panamabmsscience.com ↗

Ownership: Private
Employees: ~160
Development stage: Commercial

Overview

VaxTrials was a leading Latin American CRO specializing in the management and monitoring of vaccine clinical trials. The company contributed to over 650 clinical trials and co-authored more than 350 scientific journals. Its expertise spans interventional and non-interventional studies for vaccines targeting major infectious diseases. In October 2023, it was acquired by Emmes to expand global reach in vaccine research.

Therapeutic areas: Infectious Diseases
Modalities: VaccineBiologicDevice
Industry: Contract Research Organization

Partnerships

Biopharmaceutical companies developing vaccinesPublic-private partnerships in vaccine research

Beyond the preview

Go deeper on VaxTrials.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VaxTrials.

Explore the full profile